These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 25361539)

  • 21. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
    Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
    Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis.
    Veehof MM; ten Klooster PM; Taal E; van Riel PL; van de Laar MA
    J Rheumatol; 2008 Apr; 35(4):610-7. PubMed ID: 18322989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus.
    Thibault T; Rajillah A; Bourredjem A; Corneloup M; Maurier F; Wahl D; Muller G; Aumaitre O; Sève P; Blaison G; Besancenot JF; Martin T; Magy-Bertrand N; Samson M; Arnaud L; Amoura Z; Devilliers H;
    Rheumatology (Oxford); 2024 May; 63(5):1447-1455. PubMed ID: 37589711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
    Wolfe F; Michaud K; Li T; Katz RS
    J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus.
    Wang SL; Wu B; Leng L; Bucala R; Lu LJ
    PLoS One; 2013; 8(5):e63795. PubMed ID: 23717486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature.
    Castelino M; Abbott J; McElhone K; Teh LS
    Rheumatology (Oxford); 2013 Apr; 52(4):684-96. PubMed ID: 23264550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
    Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
    Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric validation of the Brief Pain Inventory-Short Form in patients with systemic lupus erythematosus in the United States.
    Naegeli AN; Tomaszewski EL; Al Sawah S
    Lupus; 2015 Nov; 24(13):1377-83. PubMed ID: 26038345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter study to assess presenteeism in systemic lupus erythematosus and its relationship with clinical and sociodemographic features.
    Cosatti MA; Muñoz S; Alba P; Helling CA; Roverano S; Sarano J; Malm-Green S; Danielsen M; Medina Bornachera D; Alvarez A; Eimon A; Pendón G; Mayer M; Marin J; Catoggio C; Pisoni CN
    Lupus; 2018 Jan; 27(1):33-39. PubMed ID: 28385125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsiveness of the testing morbidities index in colonoscopy.
    Swan JS; Hur C; Lee P; Motazedi T; Donelan K
    Value Health; 2013; 16(6):1046-53. PubMed ID: 24041354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adaptation and validation of the Spanish version of a disease-specific quality of life measure in patients with systemic lupus erythematosus: the Lupus quality of life].
    González-Rodríguez V; Peralta-Ramírez MI; Navarrete-Navarrete N; Callejas-Rubio JL; Santos Ruiz AM; Khamashta M
    Med Clin (Barc); 2010 Jan; 134(1):13-6. PubMed ID: 19647276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.
    Bourré-Tessier J; Clarke AE; Kosinski M; Mikolaitis-Preuss RA; Bernatsky S; Block JA; Jolly M
    Lupus; 2014 Dec; 23(14):1452-9. PubMed ID: 25081500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life of patients with systemic lupus erythematosus in Asia: how can this be improved?
    Thumboo J; Fong KY
    Lupus; 2010 Oct; 19(12):1430-5. PubMed ID: 20947553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.
    Jiang HZ; Lin ZG; Li HJ; -Du Q; -Tian W; Wang SY; Guan SQ; Mei YF
    Clin Rheumatol; 2018 Jan; 37(1):151-160. PubMed ID: 29168029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the disease-specific LupusQoL to the SF-6D.
    Meacock R; Harrison M; McElhone K; Abbott J; Haque S; Bruce I; Teh LS
    Qual Life Res; 2015 Jul; 24(7):1749-58. PubMed ID: 25510215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a disease-specific health-related quality of life measure in adult Portuguese patients with systemic lupus erythematosus: LupusQoL-PT.
    Faria R; Alves R; Oliveira DG; Vasconcelos C
    ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):210-218. PubMed ID: 35924368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus.
    Urowitz M; Gladman DD; Ibañez D; Sanchez-Guerrero J; Bae SC; Gordon C; Fortin PR; Clarke A; Bernatsky S; Hanly JG; Wallace DJ; Isenberg D; Rahman A; Merrill J; Ginzler E; Alarcón GS; Fessler B; Khamashta M; Steinsson K; Petri M; Dooley M; Bruce IN; Manzi S; Sturfelt G; Nived O; Ramsey-Goldman R; Zoma A; Maddison P; Kalunian K; van Vollenhoven R; Aranow C; Romero Diaz J; Stoll T
    Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1374-9. PubMed ID: 24497416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.